{"id":"https://openalex.org/W3210184963","doi":"https://doi.org/10.1111/vox.13213","title":"Evaluation of prophylactic polyclonal anti\u2010D antibodies: Differences in Fc\u2010glycosylation in commercial products","display_name":"Evaluation of prophylactic polyclonal anti\u2010D antibodies: Differences in Fc\u2010glycosylation in commercial products","publication_year":2021,"publication_date":"2021-10-26","ids":{"openalex":"https://openalex.org/W3210184963","doi":"https://doi.org/10.1111/vox.13213","mag":"3210184963","pmid":"https://pubmed.ncbi.nlm.nih.gov/34699082","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9298374"},"language":"en","primary_location":{"id":"doi:10.1111/vox.13213","doi":"https://doi.org/10.1111/vox.13213","is_oa":true,"landing_page_url":"https://doi.org/10.1111/vox.13213","pdf_url":null,"source":{"id":"https://openalex.org/S56953219","display_name":"Vox Sanguinis","issn_l":"0042-9007","issn":["0042-9007","1423-0410"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sanguinis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1111/vox.13213","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017992138","display_name":"Filippo Mori","orcid":"https://orcid.org/0000-0001-8940-5415","observed_orcids":["https://orcid.org/0000-0001-8940-5415"]},"institutions":[{"id":"https://openalex.org/I4210166386","display_name":"Kedrion (Italy)","ror":"https://ror.org/05ymjt203","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210166386"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Filippo Mori","raw_affiliation_strings":["Department of Research and Innovation, Kedrion S.p.A., Lucca, Italy"],"raw_orcid":"https://orcid.org/0000-0001-8940-5415","affiliations":[{"raw_affiliation_string":"Department of Research and Innovation, Kedrion S.p.A., Lucca, Italy","institution_ids":["https://openalex.org/I4210166386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029400644","display_name":"Salvatore Alfonso","orcid":"https://orcid.org/0000-0002-3816-7477","observed_orcids":["https://orcid.org/0000-0002-3816-7477"]},"institutions":[{"id":"https://openalex.org/I4210166386","display_name":"Kedrion (Italy)","ror":"https://ror.org/05ymjt203","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210166386"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alfonso Salvatore","raw_affiliation_strings":["Department of Industrial Development, Kedrion S.p.A., Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Industrial Development, Kedrion S.p.A., Naples, Italy","institution_ids":["https://openalex.org/I4210166386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011244698","display_name":"Ester Ascione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166386","display_name":"Kedrion (Italy)","ror":"https://ror.org/05ymjt203","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210166386"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ester Ascione","raw_affiliation_strings":["Department of Industrial Development, Kedrion S.p.A., Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Industrial Development, Kedrion S.p.A., Naples, Italy","institution_ids":["https://openalex.org/I4210166386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082724389","display_name":"Raffaele Di Marzo","orcid":"https://orcid.org/0000-0001-7519-3634","observed_orcids":["https://orcid.org/0000-0001-7519-3634"]},"institutions":[{"id":"https://openalex.org/I4210166386","display_name":"Kedrion (Italy)","ror":"https://ror.org/05ymjt203","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210166386"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Raffaele Di Marzo","raw_affiliation_strings":["Therapeutic Area Lead, Global Medical Affairs Department, Kedrion S.p.A., Lucca, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Lead, Global Medical Affairs Department, Kedrion S.p.A., Lucca, Italy","institution_ids":["https://openalex.org/I4210166386"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021786083","display_name":"Bernard J. Fox","orcid":"https://orcid.org/0000-0001-6362-5196","observed_orcids":["https://orcid.org/0000-0001-6362-5196"]},"institutions":[{"id":"https://openalex.org/I65163767","display_name":"National Institute for Biological Standards and Control","ror":"https://ror.org/03dnc6n82","country_code":"GB","type":"facility","lineage":["https://openalex.org/I65163767"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bernard Fox","raw_affiliation_strings":["Biotherapeutics Division, National Institute for Biological Standards and Control (NIBSC), Potters Bar, Herts, UK"],"raw_orcid":"https://orcid.org/0000-0001-6362-5196","affiliations":[{"raw_affiliation_string":"Biotherapeutics Division, National Institute for Biological Standards and Control (NIBSC), Potters Bar, Herts, UK","institution_ids":["https://openalex.org/I65163767"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017992138"],"corresponding_institution_ids":["https://openalex.org/I4210166386"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":{"value":3600,"currency":"USD","value_usd":3600},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"117","issue":"4","first_page":"624","last_page":"625"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rh-isoimmunization","display_name":"Rh isoimmunization","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hemolytic-disease-of-the-newborn","display_name":"hemolytic disease of the newborn","score":0.8809999823570251},{"id":"https://openalex.org/keywords/fc-glycosylation","display_name":"Fc glycosylation","score":0.8629999756813049},{"id":"https://openalex.org/keywords/fucosylation","display_name":"fucosylation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/galactosylation","display_name":"galactosylation","score":0.9679999947547913},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.42100000381469727},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.8379999995231628},{"id":"https://openalex.org/keywords/glycomics","display_name":"glycomics","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2779212266","wikidata":"https://www.wikidata.org/wiki/Q17053974","display_name":"Fucosylation","level":4,"score":0.8723660707473755},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7482647895812988},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.7128533720970154},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.7065654397010803},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.6993749141693115},{"id":"https://openalex.org/C106686826","wikidata":"https://www.wikidata.org/wiki/Q741206","display_name":"Glycomics","level":4,"score":0.47737547755241394},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.4442817270755768},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.41722118854522705},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3979039192199707},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3803507089614868},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33737385272979736},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3058236837387085},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.17226538062095642}],"mesh":[{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018029","descriptor_name":"Rho(D) Immune Globulin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/vox.13213","doi":"https://doi.org/10.1111/vox.13213","is_oa":true,"landing_page_url":"https://doi.org/10.1111/vox.13213","pdf_url":null,"source":{"id":"https://openalex.org/S56953219","display_name":"Vox Sanguinis","issn_l":"0042-9007","issn":["0042-9007","1423-0410"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sanguinis","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9298374","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9298374/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9298374/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sang","raw_type":"Text"},{"id":"pmid:34699082","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34699082","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox sanguinis","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1111/vox.13213","doi":"https://doi.org/10.1111/vox.13213","is_oa":true,"landing_page_url":"https://doi.org/10.1111/vox.13213","pdf_url":null,"source":{"id":"https://openalex.org/S56953219","display_name":"Vox Sanguinis","issn_l":"0042-9007","issn":["0042-9007","1423-0410"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vox Sanguinis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3210184963.pdf","grobid_xml":"https://content.openalex.org/works/W3210184963.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2095934713","https://openalex.org/W2140834734","https://openalex.org/W3003191003","https://openalex.org/W3094649508","https://openalex.org/W3130132448"],"related_works":["https://openalex.org/W2095934713","https://openalex.org/W2077050846","https://openalex.org/W2073535579","https://openalex.org/W2140834734","https://openalex.org/W2991381152","https://openalex.org/W2034498773","https://openalex.org/W2510856156","https://openalex.org/W2559658356","https://openalex.org/W2530354179","https://openalex.org/W2075688879"],"abstract_inverted_index":{"We":[0,165,434,461,478],"are":[1,333,352,363,410],"writing":[2],"to":[3,7,67,81,85,122,167,200,232,295,376,418,424,436,440,442,454],"share":[4],"our":[5,395],"efforts":[6],"help":[8],"patients":[9],"in":[10,69,129,163,336,364,367,374,412,452,457,519,532],"preventing":[11],"RhD":[12,37,42],"Disease,":[13],"an":[14,36,41,263],"alloimmune":[15],"condition":[16],"also":[17,479],"known":[18],"as":[19,304],"Haemolytic":[20],"Disease":[21],"of":[22,62,75,89,102,116,172,207,238,243,310,315,321,341,401,408,446,449,475],"the":[23,26,82,86,100,114,123,130,169,183,311,326,337,354,368,426,443,447,455,467,471,520,533],"Foetus":[24],"and":[25,73,109,149,159,179,196,224,240,285,298,339,346,373,392,403,405,414,430,473,483,491,497],"Newborn":[27],"(HDFN)":[28],"[1].":[29,52],"To":[30],"prevent":[31],"a":[32,60,95,104,250,272,305],"pathogenic":[33],"immune":[34,131],"reaction,":[35],"negative":[38],"mother":[39],"carrying":[40],"positive":[43],"foetus":[44],"should":[45],"receive":[46],"hyperimmune":[47],"polyclonal":[48],"RhD-specific":[49],"IgG":[50,55,90],"antibodies":[51],"Monoclonal":[53],"anti-D":[54,70,91,142,175,202,209,214,239,323,345,369,431,450,489],"have":[56],"been":[57],"produced":[58],"by":[59],"variety":[61],"methods":[63,193],"that":[64,141,398],"give":[65],"rise":[66],"differences":[68,77,335],"Immunoglobulin":[71],"activity":[72],"some":[74],"these":[76,126],"can":[78],"be":[79,156,514,527],"attributed":[80],"glycans":[83],"linked":[84],"Fc":[87],"region":[88],"[2].":[92],"Glycomics":[93],"is":[94,118,422],"rapidly":[96],"developing":[97],"discipline":[98],"with":[99,144,182,271,325],"aim":[101],"identifying":[103],"relationship":[105],"between":[106,428],"glycan":[107,212,296,300,342,357,492],"structures":[108,297,343,351,362],"protein":[110,229],"functionality.":[111],"In":[112,348],"particular,":[113],"glycosylation":[115,170,429,459],"immunoglobulins":[117,451],"extensively":[119],"studied":[120],"due":[121],"important":[124,381],"role":[125],"proteins":[127],"play":[128],"response":[132],"[3].":[133],"Previously":[134],"published":[135],"work":[136,421,499],"[4,":[137,379,390],"5]":[138,380,391],"has":[139],"shown":[140],"products":[143,215,370,416],"low":[145,377],"fucose":[146],"(low":[147],"fucosylation)":[148],"high":[150],"galactose":[151],"(high":[152],"galactosylation)":[153],"content":[154],"may":[155],"more":[157],"potent":[158],"protective":[160],"for":[161,204,245,330,344,382,388,466,486,502,510],"prophylaxis":[162],"HDFN.":[164],"decided":[166],"investigate":[168],"pattern":[171],"two":[173],"prophylactic":[174,322],"immunoglobulin":[176,185,432],"products,":[177],"IMMUNORHO\u00ae":[178],"RhoGam\u00ae,":[180],"along":[181],"intravenous":[184],"(IVIG)":[186],"product":[187],"IgVena\u00ae.":[188],"European":[189],"Pharmacopoeia":[190],"(Ph":[191],"Eur)":[192],"2.7.13":[194],"B":[195],"C":[197],"were":[198,216,283,293],"used":[199],"determine":[201],"potency":[203,490],"three":[205,241],"lots":[206,237,242],"each":[208,299],"product.":[210],"For":[211],"analysis,":[213],"affinity":[217],"purified":[218,226],"on":[219,227,262],"group":[220],"O,":[221],"R2R2":[222],"cells":[223],"further":[225],"immobilised":[228],"G":[230],"prior":[231],"preparing":[233],"all":[234],"samples":[235],"(six":[236],"IVIG)":[244],"Mass":[246],"Spectrometry":[247],"analysis":[248],"using":[249,279,288],"GlycoWorks":[251],"RapiFluor":[252],"MS":[253],"kit":[254],"(Waters,":[255,269,277],"UK).":[256],"Glycan":[257,274],"separation":[258],"was":[259,302],"carried":[260],"out":[261],"Acquity":[264],"UPLC":[265],"H-class":[266],"Bio":[267],"system":[268],"UK)":[270,278],"BEH":[273],"Amide":[275],"column":[276],"in-house":[280],"methodology.":[281],"Data":[282,512,525],"acquired":[284],"processed":[286],"manually":[287],"Empower":[289],"3.1":[290],"software.":[291],"Peaks":[292],"assigned":[294,316],"structure":[301],"expressed":[303],"percentage":[306,313],"relative":[307],"peak":[308],"area":[309,314],"total":[312],"peaks.":[317],"All":[318],"six":[319],"batches":[320],"complied":[324],"Ph":[327],"Eur":[328],"specification":[329],"potency.":[331],"There":[332],"clear":[334],"mixture":[338],"abundance":[340,366],"IVIG.":[347,419],"IVIG,":[349],"fucosylated":[350],"typically":[353],"most":[355],"abundant":[356],"forms":[358],"(Table":[359,371],"1).":[360],"Digalactosyl":[361],"greater":[365],"2)":[372],"addition":[375],"fucosylation":[378,409],"enhanced":[383],"ADCC":[384],"activity.":[385],"As":[386],"reported":[387],"Rhophylac\u00ae":[389],"RhoGam":[393,415],"[5]":[394],"results":[396],"show":[397],"higher":[399],"levels":[400,407],"sialylation":[402],"galactosylation":[404],"lower":[406],"present":[411],"IMMUNORHO":[413],"compared":[417],"Further":[420],"required":[423],"elucidate":[425],"link":[427],"function.":[433],"intend":[435],"collect":[437],"additional":[438],"data":[439],"contribute":[441],"better":[444],"understanding":[445],"properties":[448],"relation":[453],"variation":[456],"IgG-Fc":[458],"profiles.":[460],"gratefully":[462],"acknowledge":[463],"Roberto":[464],"Crea":[465],"insightful":[468],"discussion":[469],"during":[470],"preparation":[472],"editing":[474],"this":[476],"article.":[477],"thank":[480],"Giles":[481],"Sharp":[482],"Ben":[484],"Cowper":[485],"respectively":[487],"performing":[488],"analysis.":[493],"F.M.,":[494],"A.S.,":[495],"E.A.":[496],"R.D.":[498],"full":[500,508],"time":[501,509],"Kedrion":[503,517,530],"Biopharma":[504],"Inc.":[505],"B.F.":[506],"works":[507],"NIBSC.":[511],"will":[513,526],"stored":[515,528],"at":[516,529],"S.p.A.":[518,531],"Global":[521,534],"Medical":[522,535],"Affairs":[523,536],"Department.":[524,537]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-11-08T00:00:00"}